
TREATMENTS
Exploring new frontiers for the treatment of Vision Disorder
TREATMENTS
Exploring new frontiers for the treatment of Vision Disorder
17+ Years of using patented and proven stem cell treatment for Vision Disorders like Optic Nerve Atrophy, Age Related Macular Degeneration, Retinopathy, & Eye Injuries.
The human eye is a complex yet important organ that gives us the ability to visualize the world. Many major components like nerves and lenses work in tandem to transmit the image to the occipital lobe of the brain through optic nerves. Photoreceptor cells, present in our eyes help us to distinguish between colors and black and white images. Rectus muscles control the movement of the eyes, oculometer nerves control the rectus muscles. The lacrimal gland is in charge to release tears for lubrication. Degeneration or damage in any of these components can cause problems with vision. Ignoring these may lead to loss of vision or vision disorders like corneal disease, macular degeneration, retinitis pigmentosa, optic nerve therapy, etc.
Conventional treatment for disorders such as myopia, hypermetropia, etc. typically is done through corrective prescription lenses. Vision Disorders such as cataracts, glaucoma, macular degeneration, and retinitis pigmentos require advanced medical and surgical treatments. Damage to the eye tissue is not reversed with conventional therapies. Once the pre-assessment of the patient has been done in-house, isolated stem cells can be channelized to be corneal cells, photoreceptor cells, optic nerves, muscle cells, etc. in the eye to regain its normal function back.
The stem cells are administered in the body through veins, lumbar puncture or directly in the retina of the eye. Upon infusion, these cells can create a microenvironment necessary for replacing dead or damaged cells of the macula with the fresh cells. Stem cells are also known to have vasculogenetic properties with which they can induce the new blood vessel formation replacing leaky or damaged vessels of the eye. Stem Cell Treatment at Nutech MediWorld helps reboot and revive the damaged nerve cells to restore and improve functions of the eye.
At Nutech MediWorld, we assess the patients’ clinical condition using conventional systems to check their eligibility for stem cell treatment for Vision Disorders including Optic Nerve Therapy, Retinitis Pigmentosa and Macular Degeneration among others.
We also conduct an additional round of thorough assessment using our patented NFS
(Nutech Functional System) protocols whereby condition-based sets of parameters have been pre-devised for a finer assessment of the patient’s condition (and progress).
After evaluating the specific patient’s condition, a unique/bespoke treatment protocol is decided. This protocol is based on our proprietary stem cell platform, Reostem®.
The patient’s progress is monitored on a weekly basis to further optimise treatment protocols depending on the patient’s response.
At the end of the treatment, a complete assessment is done to track progress from when the patient came into where he/she has reached now. If required, a follow-up protocol is recommended.
At Nutech MediWorld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Vision Disorder patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient.
At Nutech MediWorld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Vision Disorders Patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient
At Nutech MediWorld, we assess the patients’ clinical condition using conventional systems to check their eligibility for stem cell treatment for Vision disorders including Optic Nerve Therapy, Retinitis Pigmentosa, Macular Degeneration among others.
We also conduct an additional round of thorough assessment using our patented NFS
(Nutech Functional System) protocols whereby condition-based sets of parameters have been pre-devised for a finer assessment of the patient’s condition (and progress).
After evaluating the specific patient’s condition, a unique/bespoke treatment protocol is decided. This protocol is based on our proprietary stem cell platform, Reostem ®.
The patient’s progress is monitored on a weekly basis to further optimize treatment protocols depending on the patient’s response
At the end of the treatment, a complete assessment is done to track progress from when the patient came into where he/she has reached now. If required, a follow-up protocol is recommended.
We use SCT-N® and SCT-NX® products, based on a proprietary stem cell platform, ReoStem®. ReoStem® is a unique, replicable, clinical-stage technology platform for the generation of allogenic stem cells.
Nutech MediWorld’s regenerative medicine products are universally applicable: they do not require tissue-matching or the co-administration of immunosuppressive drugs.
There is absolutely no evidence of teratoma generation or tumorigenesis associated with SCT-N® or SCT-NX® use in over 17 years of clinical practice across thousands of patients.
Unique cell culture methodology allows scalability of cell expansion and production.